Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/27/1999CN1233188A Medicines comprising Rho kinase inhibitor
10/27/1999CN1233187A HIVp-17 peptide fragment, compositions containing and methods for producing and using same
10/27/1999CN1233184A Pharmaceutical and comestic formulations with antimicrobial activity
10/27/1999CN1233183A Pharmaceutical and cosmetic antiacne formulations containing plant extracts (Krameria triandra or mesua ferrea)
10/27/1999CN1233182A Citrus peel extract as 3-hydroxy-3-methyl glutaryl-CoA (HMG-CoA) reductase inhibitor
10/27/1999CN1233181A Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
10/27/1999CN1233180A Treatment of the common cold or allergic rhinitis
10/27/1999CN1233179A Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
10/27/1999CN1233178A Pyrazolinones to treat disturbances of potency
10/27/1999CN1233177A Therapeutic treatment for VEGF related diseases
10/27/1999CN1233176A Substituted tricyclics
10/27/1999CN1233175A Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
10/27/1999CN1233174A Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
10/27/1999CN1233173A Therapeutic methods and compositions involving isoflavones
10/27/1999CN1233172A Secondary cataract inhibitor
10/27/1999CN1233171A Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
10/27/1999CN1233170A Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
10/27/1999CN1233169A Process for the manufacture of a pulverous preparation
10/27/1999CN1233168A Wrinkling modifiers
10/27/1999CN1233150A Method for inhibiting the expression of FAS
10/27/1999CN1232817A Acetoacetarylamides
10/27/1999CN1232701A Process for preparing herbal compositions for treatment of bronchitis and respiratory disorders with anticancer properties
10/27/1999CN1232681A Hog cholera treating medicine
10/27/1999CN1232674A Chinese medicine preparation for curing radically chronic tonsilitis and intractable laryngopharyngitis and its preparation and usage
10/27/1999CN1232669A Phosphatide oral liquid and its production
10/27/1999CN1232668A Method for producing water dispersible sterol formulations
10/27/1999CN1232667A Acyl tobri preparation as angiotensin invertase inhibitor
10/27/1999CN1232665A Antimicrobial composition
10/27/1999CN1045964C Heterocyclic compounds and their preparation and use
10/27/1999CN1045962C Pyridopyridazinone or pyridopyridazine-thione compound, intermediate for preparing it, pharmaceutical composite containing the same and its use
10/27/1999CN1045957C Tricyclic benzazepine, their application and preparation
10/27/1999CN1045955C Quinoline derivative and its producing process and its application and pharmaceutical composition containing the same derivative
10/27/1999CN1045895C Compound immune antibiotic
10/27/1999CN1045887C Traumatic ointment and producing method thereof
10/27/1999CN1045884C High dose formulations containing active agent
10/27/1999CA2269995A1 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
10/27/1999CA2269888A1 Pharmaceutical forms for the oral administration of mesna
10/26/1999US5973204 3-demethyl benzo(a)heptalene derivative used as antiinflammatory and muscle relaxant
10/26/1999US5973201 Phenylacetamide derivatives
10/26/1999US5973191 Selective inhibitors of prostaglandin endoperoxide synthase-2
10/26/1999US5973188 Anticoagulant; prevention cell, protein binding
10/26/1999US5973172 14-α,17-α-C2 -bridged norprogesterone derivatives
10/26/1999US5973169 Ipriflavone preparation process
10/26/1999US5973167 Sulfonamide group, ether containing acid
10/26/1999US5973163 Oxazolidine carboxylic acid intermediates for esterification of taxanes
10/26/1999US5973155 Process for preparing (-)-trans-N-p-fluorobenzoylmethyl-4-(p-fluorophenyl)-3-[[3,4-(methylened ioxy)phenoxy]methyl]-piperidine
10/26/1999US5973152 Certain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligands
10/26/1999US5973150 Pharmacologically active enantiomers
10/26/1999US5973136 Inverted chimeric oligonucleotides
10/26/1999US5973128 Glycolipid mimics and methods of use thereof
10/26/1999US5973111 Novel compounds that are capable of binding to the active site of interleukin-1b-converting enzyme (ice) and inhibiting activity of that enzyme; administering to treat inflammatory, autoimmune, and neurodegenerative diseases
10/26/1999US5973011 Administration of 6 mg/kg/day of an organic nitrate to an individual to maintain or improve endothelial function
10/26/1999US5973009 Antioxidant and cytoprotecting activity
10/26/1999US5973007 Use of inhibitors of retinoic acid activity for wound healing
10/26/1999US5973006 Nervous system disorders; alzheimer's disease; huntington disease; parkinson's disease
10/26/1999US5973004 L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism
10/26/1999US5973003 Treatment of thrombosis, stroke, myocardial infarction, inflammation and arteriosclerosis
10/26/1999US5973002 Treatment of gastrointestinal ulcer in a patient comprising the step of contacting the skin of said patient with transdermal c 1-4 alkyl ester of prostaglandin e1 or 6-keto prostaglandin e1.
10/26/1999US5972995 One or more flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues.
10/26/1999US5972992 Comprising taxol and a pharmaceutically-acceptable carrier wherein said pharmaceutical taxol composition has a ph less than or equal to 7; improved stability
10/26/1999US5972991 Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
10/26/1999US5972990 Administering angiotensin ii inhibitors, such as losartan to patients who are otherwise free of indications for angiotensin ii inhibition treatment and have left ventricular ejection fraction of 40% or less
10/26/1999US5972989 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/26/1999US5972988 Method for treatment of chronic bronchitis using indole compounds
10/26/1999US5972987 Detection lice with dye
10/26/1999US5972986 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/26/1999US5972985 Histidine containing nutriceutical compositions
10/26/1999US5972982 Containing 5-to 9-membered heteroaryl mono- or bicyclic ring system having no more than 1 carbonyl carbon in the ring system; viricides, bactericides
10/26/1999US5972980 Method for treating and preventing inflammation and atherosclerosis
10/26/1999US5972979 Tricyclic spiro compounds as 5HT1D receptor antagonists
10/26/1999US5972977 Ophthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositions
10/26/1999US5972976 Aminostilbazole derivative and medicine
10/26/1999US5972975 Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
10/26/1999US5972974 Transdermal nicotine metabolites and human body weight
10/26/1999US5972973 Sulfonylurea-glitazone combinations for diabetes
10/26/1999US5972972 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
10/26/1999US5972970 Oxazolidinedione derivatives, their production and use
10/26/1999US5972969 Methods of combatting infectious disease using dicationic bis-benzimidazoles
10/26/1999US5972968 Interleukin inhibitor
10/26/1999US5972967 Intravenous administering 2-(butylsulfonylamino)-3-(4-(4-(piperidin-4-yl)butoxyphenyl)pr opionic acid
10/26/1999US5972965 4,5-diaryl oxazole derivatives
10/26/1999US5972964 Aminomethylindans, -benzofurans and -benzothiophenes
10/26/1999US5972963 An antidepressant, modulators of neurotransmitter function such as serotonergic and adrenergic, dopaminergic agents
10/26/1999US5972962 Treatment of pruritus
10/26/1999US5972961 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
10/26/1999US5972959 Oxime derivatives, their preparation and their therapeutic use
10/26/1999US5972957 Analgesics and antiarthritic agent
10/26/1999US5972956 Inhibiting amyloid aggregation in a mammal by administering a 1-(mono or di substituted, or cyclized amino-alkyl-amino), 4-nitro,5-(hydrogen or alkyl), acridine compounds; useful in treating alzheimer's disease
10/26/1999US5972955 Water soluble C-ring analogues of 20(S)-camptothecin
10/26/1999US5972954 Use of methylnaltrexone and related compounds
10/26/1999US5972953 Morphinan derivative; usefal as preventive and therapuetic agents of ischemic brain disorders, brain nerve cell disorders and dementia
10/26/1999US5972952 Neuroprotective pharmaceutical composition containing stereoisomers of arylcyclohexylamines
10/26/1999US5972951 Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists
10/26/1999US5972947 Anticoagulant, cardiovascular disorders, antiinflammatory agents, osteoporosis, antitumor agent
10/26/1999US5972946 Nervous system disorders; psychological disorders
10/26/1999US5972944 Use of thiazolidinedione derivatives in the treatment of anovulation, hyperandrogenism and hirsutism
10/26/1999US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999US5972939 Cyclopentene derivatives useful as antagonists of the motilin receptor
10/26/1999US5972938 Method for treating or preventing psychoimmunological disorders
10/26/1999US5972937 Treating central nervous system disorders such as anxiety, depression, epilepsy, obsessive compulsive disorders, migraine, alzheimers disease, sleep disorders, feeding disorders such as anorexia and bulimia, panic attacks